SCHEMBL8382011

SCHEMBL8382011

COc1cccc2c1C(=O)c1c(O)cccc1C2=O

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.84
KMT2A Q03164 3/20 0.84
EGFR P00533 1/20 0.81
PIM1 P11309 1/20 0.81
MAPT P10636 4/20 0.69
ALDH1A1 P00352 3/20 0.69
MAOA P21397 2/20 0.69
TSHR P16473 2/20 0.69
MAPK1 P28482 2/20 0.69
TDP1 Q9NUW8 2/20 0.69
LMNA P02545 2/20 0.69
HTT P42858 2/20 0.69
HPGD P15428 1/20 0.69
ALOX15 P16050 1/20 0.69
MAOB P27338 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
HSD17B10 Q99714 1/20 0.69
ELANE P08246 10/20 0.68
P4HB P07237 1/20 0.58
CTSG P08311 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11797236 0.95 EGFR (0.84) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL7786291 0.91 MEN1 (1.00) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL11528272 0.90 EGFR (1.00) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL8947495 0.89 EGFR (0.73) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL16226264 0.85 ELANE (0.73) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL16225768 0.85 EGFR (0.64) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL8930315 0.85 MAPT (0.73) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL16226324 0.85 ALDH1A1 (0.69) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL5146135 0.84 SMN1; SMN2 (0.69) MEN1KMT2AEGFRPIM1MAPT
SCHEMBL3417492 0.83 EGFR (0.76) MEN1KMT2AEGFRPIM1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116178411-A Small molecular probe for detecting p53 dysfunction and preparation method and application thereof 山西大学 2023-05-30 CN disclosed
US-5922891-A ANTI-INFLAMMATORY AGENTS WHICH INHIBIT LIPOXYGENASE PATHWAYS AND THERFORE PROLIFERATIVE ACTIVITY OF PRODUCTS OF THE PATHWAYS; SUPPRESSION OF IRON-DEPENDENT GENERATION OF OXYGEN FREE RADICALS, TREATMENT OF PSORIASIS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 1999-07-13 US disclosed
WO-1996040623-A1 2-SUBSTITUTED 1,8-DIHYDROXY-9(10H)-ANTRACENONE AS PROLIFERATION AND 5-LIPOXYGENASE INHIBITORS TEVA PHARMACEUTICAL INDUSTRIES LTD. (US) 1996-12-19 WO disclosed
US-5053431-A Antitumor-anticarcinogenic agents SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-10-01 US disclosed
WO-1990008759-A1 DERIVATIVES OF CHRYSOPHANOL SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1990-08-09 WO disclosed